Tumor necrosis factor alpha—an underestimated risk predictor in patients undergoing transcatheter aortic valve replacement (TAVR)?
Moritz Mirna(Paracelsus Medical University), Michael Lichtenauer(Paracelsus Medical University), Dzeneta Fejzic(University of Salzburg), Vera Paar(Paracelsus Medical University), Daniel Kretzschmar(Friedrich Schiller University Jena), Alexander Lauten(German Centre for Cardiovascular Research), Christian Jung(Heinrich Heine University Düsseldorf), Peter Jirak(Paracelsus Medical University), Marcus Franz(Jena University Hospital), Lukas J. Motloch(Johannes Kepler University of Linz), Brunilda Alushi(Deutsches Herzzentrum der Charité), Uta C. Hoppe(Baker Heart and Diabetes Institute), Hermann Blessberger(Johannes Kepler University of Linz), Clemens Steinwender(Kepler Universitätsklinikum), Mario Holnthoner(University of Salzburg), Albert Topf(Paracelsus Medical University), Christian Reiter(Johannes Kepler University of Linz), Jürgen Kammler(Johannes Kepler University of Linz), Joerg Kellermair(Kepler Universitätsklinikum)
Cited by 6
Related Papers
Effect of Renal Sympathetic Denervation on Glucose Metabolism in Patients With Resistant Hypertension
|Circulation|2011|569
Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification
|European Heart Journal|2018|377
Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation
|Journal of the American College of Cardiology|2017|331
Predictors of Left Ventricular Outflow Tract Obstruction After Transcatheter Mitral Valve Replacement
|JACC: Cardiovascular Interventions|2019|287